Camarillo, CA, United States of America

Alan Herman

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Coherus Biosciences, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Herman. Retrieved from https://idiyas.com/inventor/alan-herman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alan Herman - Innovator in Pharmaceutical Formulations

Introduction

Alan Herman is a notable inventor based in Camarillo, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of etanercept compositions. His work focuses on improving the stability and quality of these important medications.

Latest Patents

Alan Herman holds a patent for "Etanercept formulations exhibiting marked reduction in sub-visible particles." This invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage. It emphasizes a substantial reduction in sub-visible particles, along with methods of manufacture, administration, and articles of manufacture.

Career Highlights

Alan is associated with Coherus Biosciences, Inc., where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in the formulation of biologic drugs, enhancing their efficacy and safety for patients.

Collaborations

Throughout his career, Alan has collaborated with esteemed colleagues, including Mark Cornell Manning and Brian P Murphy. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alan Herman's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work not only advances the field but also improves patient outcomes through enhanced drug stability and safety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…